Patent claiming dose reduction for poor metabolizers affirmed at Federal Circuit.
Hatch Waxman Litigation
April 22, 2018
Court finds Meda Pharmaceuticals’ delay asserting certificate of correction precludes adding the corrected claim to the lawsuit.
June 20, 2017
246 Fifth Avenue, Suite 422
New York NY 10001
Subscribe to our blog:
© 2017 Sullivan IP Solutions, LLC. All Rights Reserved.